Hetero & Gilead Partner for HIV Drug Lenacapavir Access
October 2, 2024 19:23
Hetero and Gilead have partnered to expand access to lenacapavir, a groundbreaking HIV treatment, in 120 low- and middle-income countries. This partnership aims to improve treatment options and...